- Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. The Lancet. Oncology. 2017 Academic Article GET IT
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Times cited: 29
- A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Academic Article GET IT
Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system.
Times cited: 53
Treatment failure in endometrial carcinoma.
Obstetrics and gynecology.
Times cited: 52